In the past 90 days, the zacks consensus estimate for its earnings has moved 3.1% south to $4.36. Abiomed is witnessing a negative estimate revision trend for 2021.
The brokerage presently has a $369.00 price target on the medical equipment provider's stock.
Abmd stock forecast zacks. Abiomed (abmd) came out with quarterly earnings of $1.03 per share, beating the zacks consensus estimate of $0.98 per share. (abmd) is engaged in developing, manufacturing and marketing of medical products, designed to assist or replace the. Positive dynamics for abiomed shares will prevail with possible volatility of 2.930%.
Zacks investment research's price objective would suggest a potential upside of 7.71% from the. Want the latest recommendations from zacks investment research? In the past 90 days, the zacks consensus estimate for its earnings has moved 3.2% south to $4.23.
The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Find the latest abiomed, inc. Abiomed, inc (abmd) q1 2022 earnings call transcript.
This compares to earnings of $1.01 per share a year ago. Click to get this free report abiomed, inc. Zacks investment research downgraded shares of abiomed (nasdaq:abmd) from a hold rating to a sell rating in a report published on tuesday morning, zacks.com reports.
The figure surpassed the zacks consensus estimate by 5.1%. Headquartered in danvers, ma and founded in 1981, abiomed inc. Abiomed (abmd) beats on q2 earnings, lowers fy22 guidance.
Abiomed (abmd) doesn t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Abmd delivered adjusted earnings per share (“eps”) of $1.03 in the second quarter of fiscal 2022, up 1.9% year over year. Abmd | complete abiomed inc.
(abmd) stock quote, history, news and other vital information to help you with your stock trading and investing. Abiomed (nasdaq:abmd) was upgraded by zacks investment research from a sell rating to a hold rating in a research note issued on wednesday, zacks.com reports. Today, you can download 7 best stocks for the next 30 days.
The zacks industry rank assigns a rating to each of the 265 x (expanded) industries based on their average zacks rank. Abiomed is witnessing a negative estimate revision trend for 2022. An industry with a larger percentage of zacks rank #1's and #2's will have a.
Zacks investment research currently has $373.00 target price on.
